FilingSEC EDGAR8-K
Lifecore Biomedical Extends Contract Manufacturing Agreement with Alcon Through 2034
· SEC accepted
StageAgreement Signed
Filing content
Lifecore extended its contract manufacturing agreement with Alcon through December 31, 2034, and established minimum purchase obligations. Starting November 1, 2026, the company is restricted from manufacturing certain competing products.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…